Theraclone Sciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
26 Pages - GLDATA58121
$250.00

Summary

Theraclone Sciences Inc (Theraclone) that develops therapeutic antibodies for the treatment of cancer and infectious diseases. The company detects antibodies that human memory B cells produce naturally in response to disease-causing agents or conditions using its proprietary technology, I-STAR. It also offers development programs on infectious disease that include novel antibodies to fight pandemic and seasonal influenza. The company’s I-STAR technology is used to identify and develop novel therapeutic antibody products for infectious diseases including human immunodeficiency virus (HIV), influenza, ebola, and cancer. It works in partnership with various companies for the commercialization of antibody therapeutic products. Theraclone is headquartered in Seattle, Washington, the US.

Theraclone Sciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Theraclone Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Theraclone Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Theraclone Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Theraclone Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Theraclone Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Theraclone Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Theraclone Sciences Raises US$8 Million In Extended Series B Financing 11
Theraclone Sciences Raises US$6 Million In Venture Financing 13
Theraclone Sciences Secures Additional US$1 Million In Extended Series B Financing 14
Theraclone Sciences Secures An Additional US$1.5 Million In Series B Venture Financing 16
Partnerships 18
University of Texas MD Anderson Cancer Center and Theraclone Sciences Form Joint Venture 18
Theraclone Sciences Enters Into Joint Venture With VLST To Form V-Gene 19
Theraclone Sciences Enters Into Co-Development Agreement With Pfizer 20
Licensing Agreements 21
Theraclone Sciences Enters into Licensing Agreement with Gilead Sciences 21
Zenyaku Kogyo Enters Into License Agreement With Theraclone 22
Theraclone Sciences Inc - Key Competitors 23
Key Employees 24
Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Theraclone Sciences Inc, Pharmaceuticals & Healthcare, Key Facts 1
Theraclone Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Theraclone Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Theraclone Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Theraclone Sciences Inc, Deals By Therapy Area, 2010 to YTD 2016 8
Theraclone Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Theraclone Sciences Raises US$8 Million In Extended Series B Financing 11
Theraclone Sciences Raises US$6 Million In Venture Financing 13
Theraclone Sciences Secures Additional US$1 Million In Extended Series B Financing 14
Theraclone Sciences Secures An Additional US$1.5 Million In Series B Venture Financing 16
University of Texas MD Anderson Cancer Center and Theraclone Sciences Form Joint Venture 18
Theraclone Sciences Enters Into Joint Venture With VLST To Form V-Gene 19
Theraclone Sciences Enters Into Co-Development Agreement With Pfizer 20
Theraclone Sciences Enters into Licensing Agreement with Gilead Sciences 21
Zenyaku Kogyo Enters Into License Agreement With Theraclone 22
Theraclone Sciences Inc, Key Competitors 23
Theraclone Sciences Inc, Key Employees 24

List of Figures
Theraclone Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Theraclone Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Theraclone Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Theraclone Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Theraclone Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Theraclone Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Theraclone Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Theraclone Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838